Write in a clean editor, then format for BMC Cancer in one click — DocuGuru applies the official BMC (BioMed Central) template with numbered references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
BMC Cancer is a peer-reviewed journal published by BMC (BioMed Central), covering Cancer Immunotherapy and Biomarkers, Ferroptosis and cancer prognosis, Breast Cancer Treatment Studies. Over its lifetime it has published 20,788 papers, which have received 622,661 citations.
| Publisher | BMC (BioMed Central) |
|---|---|
| Reference style | Numbered (Vancouver) Numbered — [1], [2] in the text 1. Smith A, Jones B, Lee C. A representative article title. BMC Cancer. 2023;12(3):45–58.
Formats any DOI in BMC Cancer style. No sign-up. |
| Publishes research in | Cancer Immunotherapy and Biomarkers Ferroptosis and cancer prognosis Breast Cancer Treatment Studies Cancer survivorship and care Global Cancer Incidence and Screening |
| ISSN | 1471-2407 |
| Citation impact (2-yr) | 3.66 |
| h-index | 205 |
| i10-index | 13,462 |
| Article processing charge | $2,195 |
| Open access | Yes — indexed in DOAJ |
| Top institutions publishing here | Sun Yat-sen University |
| Journal website | www.biomedcentral.com |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Citations each year’s papers have accumulated so far — the most recent years are still building up.
BACKGROUND: Tumor associated macrophages (TAMs) are present in high density in solid tumors. TAMs share many characteristics with alternatively activated macrophages, also called M2. They have been shown to favor tumor development and a role in chemoresistance has also been suggested. Here, we investigated the effects of M2 in comparison to M1 macrophages on cancer…
BACKGROUND: Exosomes are nanovesicles secreted by tumour cells which have roles in paracrine signalling during tumour progression, including tumour-stromal interactions, activation of proliferative pathways and bestowing immunosuppression. Hypoxia is an important feature of solid tumours which promotes tumour progression, angiogenesis and metastasis, potentially through exosome-mediated signalling. METHODS: Breast cancer cell lines were cultured under either…
BACKGROUND: Colorectal cancer (CRC) is a leading cause of cancer-associated deaths with liver metastases developing in 25-30% of those affected. Previous data suggest a survival difference between right- and left-sided liver metastatic CRC, even though left-sided cancer has a higher incidence of liver metastases. The aim of the study was to describe the liver metastatic…
BACKGROUND: A cancer diagnosis can have a substantial impact on mental health and wellbeing. Depression and anxiety may hinder cancer treatment and recovery, as well as quality of life and survival. We argue that more research is needed to prevent and treat co-morbid depression and anxiety among people with cancer and that it requires greater…
BACKGROUND: Increased collagen deposition provides physical and biochemical signals to support tumor growth and invasion during breast cancer development. Therefore, inhibition of collagen synthesis and deposition has been considered a strategy to suppress breast cancer progression. Collagen prolyl-4-hydroxylase α subunit 2 (P4HA2), an enzyme hydroxylating proline residues in -X-Pro-Gly- sequences, is a potential therapeutic target…
